Overview
The U.S. Food and Drug Administration (FDA) and the U.S. Department of Justice (DOJ) have recently increased their emphasis on bringing strict-liability criminal prosecutions under the Park Doctrine against companies and individual corporate officers for FDA-related violations. Our experience in FDA-related criminal defense work long pre-dates this recent trend, and allows us to effectively represent companies and individuals in FDA criminal enforcement actions. We have represented parties in criminal investigations involving such allegations as falsification of data; failure to properly file adverse reaction reports; improper promotion or advertising of off-label uses; product adulteration, including failure to follow Good Manufacturing Practices (GMPs); and providing illegal gratuities to FDA officials.
Contact Us
Ralph J. Caccia
202.719.7242 | rcaccia@wiley.law
Ann M. Begley
202.719.4585 | abegley@wiley.law
Ryan Michael Fournier
202.719.7389 | rfournier@wiley.law
Related Capabilities
- Digital Health
- Drug Product Development and Approval Strategies
- Enforcement & Recalls
- FDA Regulatory Compliance
- Food & Drug Due Diligence and Transactional Support
- Hatch-Waxman Act Litigation
- Human and Animal Food Ingredient Review and Approval Strategies
- Labeling, Advertising, and Promotion
- Litigation and Administrative Advocacy
- Medical Devices
- White Collar Defense & Government Investigations
Related News & Insights
- EventIntroduction to Medical Device Law and Regulation: Enforcement and ComplianceFood and Drug Law Institute (FDLI)April 14, 2022Brandon J. Moss
- EventWhat are the DOJ Enforcement Trends Regarding FDA-Regulated Companies?Food and Drug Law Institute: Enforcement, Litigation, and Compliance Conference: For the Drug, Device, Food, and Tobacco IndustriesDecember 13, 2018Brandon J. Moss